BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28254348)

  • 1. MicroRNA-21 promotes perineural invasion and impacts survival in patients with oral carcinoma.
    Yu EH; Tu HF; Wu CH; Yang CC; Chang KW
    J Chin Med Assoc; 2017 Jun; 80(6):383-388. PubMed ID: 28254348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN and miR-26b: Promising prognostic biomarkers in initiation and progression of Oral Squamous Cell Carcinoma.
    Baghaei F; Abdollahi A; Mohammadpour H; Jahanbin M; Naseri Taheri F; Aminishakib P; Emami Razavi A; Kharazifard M
    J Oral Pathol Med; 2019 Jan; 48(1):31-35. PubMed ID: 30372795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma.
    Ren W; Qiang C; Gao L; Li SM; Zhang LM; Wang XL; Dong JW; Chen C; Liu CY; Zhi KQ
    Biomarkers; 2014 Nov; 19(7):590-6. PubMed ID: 25174622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
    Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
    Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
    Cai Z; Hao XY; Liu FX
    Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
    Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
    Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
    Weaver AN; Burch MB; Cooper TS; Della Manna DL; Wei S; Ojesina AI; Rosenthal EL; Yang ES
    Mol Cancer Res; 2016 Sep; 14(9):883-91. PubMed ID: 27353029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
    Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
    Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma.
    Chang KW; Chu TH; Gong NR; Chiang WF; Yang CC; Liu CJ; Wu CH; Lin SC
    Oral Dis; 2013 Sep; 19(6):611-9. PubMed ID: 23231387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between miR-499a polymorphism and oral squamous cell carcinoma progression.
    Hou YY; Lee JH; Chen HC; Yang CM; Huang SJ; Liou HH; Chi CC; Tsai KW; Ger LP
    Oral Dis; 2015 Mar; 21(2):195-206. PubMed ID: 24690080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN allelic loss is an important mechanism in the late stage of development of oral leucoplakia into oral squamous cell carcinoma.
    Miyahara LAN; Pontes FSC; Burbano RMR; Conte Neto N; GuimarĂ£es DM; Fonseca FP; Pontes HAR
    Histopathology; 2018 Jan; 72(2):330-338. PubMed ID: 28858374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging significance of bone invasion in small-sized (4cm or less) oral squamous cell carcinoma as defined by the American Joint Committee on Cancer.
    Kuk SK; Yoon HJ; Hong SD; Hong SP; Lee JI
    Oral Oncol; 2016 Apr; 55():31-6. PubMed ID: 26880520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
    Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
    J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
    Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
    J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated autocrine chemokine ligand 18 expression promotes oral cancer cell growth and invasion via Akt activation.
    Jiang X; Wang J; Chen X; Hong Y; Wu T; Chen X; Xia J; Cheng B
    Oncotarget; 2016 Mar; 7(13):16262-72. PubMed ID: 26919103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.